Aradhana Sarin
President chez ACHILLION PHARMACEUTICALS, INC.
Fortune : 12 M $ au 30/04/2024
Postes actifs de Aradhana Sarin
Sociétés | Poste | Début | Fin |
---|---|---|---|
ACHILLION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 28/01/2020 | - |
President | 28/01/2020 | - | |
ASTRAZENECA PLC | Directeur/Membre du Conseil | 01/08/2021 | - |
Directeur Financier/CFO | 01/08/2021 | - | |
ANHEUSER-BUSCH INBEV SA/NV | Directeur/Membre du Conseil | 26/04/2023 | - |
Independent Dir/Board Member | 26/04/2023 | - |
Historique de carrière de Aradhana Sarin
Anciens postes connus de Aradhana Sarin
Sociétés | Poste | Début | Fin |
---|---|---|---|
CITIZENS, INC. | Corporate Officer/Principal | 01/06/2010 | 01/10/2017 |
UBS | Corporate Officer/Principal | - | - |
ALEXION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 02/07/2020 | - |
Directeur Financier/CFO | 01/12/2019 | - | |
Corporate Officer/Principal | 13/11/2017 | 01/12/2019 | |
President | 02/07/2020 | - | |
ORASURE TECHNOLOGIES, INC. | Directeur/Membre du Conseil | 01/01/2018 | - |
Independent Dir/Board Member | 01/01/2018 | - |
Formation de Aradhana Sarin
Stanford Graduate School of Business | Masters Business Admin |
University of Delhi | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Suisse | 2 |
Royaume-Uni | 2 |
Opérationnelle
Director/Board Member | 5 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Finance | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
ORASURE TECHNOLOGIES, INC. | Health Technology |
CITIZENS, INC. | Finance |
ASTRAZENECA PLC | Health Technology |
ANHEUSER-BUSCH INBEV SA/NV | Consumer Non-Durables |
Entreprise privées | 3 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
UBS AG
UBS AG Investment ManagersFinance UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded in 1862 and is headquartered in Zurich, Switzerland. | Finance |
- Bourse
- Insiders
- Aradhana Sarin
- Expérience